Endobronchial application of Ankaferd blood stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability

Respiratory Medicine CME

Volumn 2, Issue 3, 2009, Pages 144-146

  Arslan, Sinan ^a   Haznedaroglu, Ibrahim C ^b   Öz, Büge ^c   Goker, Hakan ^b  

^a Derince State Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ankaferd blood stopper ; Bleeding; Lung cancer

Indexed keywords

ANKAFERD; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FIBEROPTIC BRONCHOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXEMIA; LUNG HEMODYNAMICS; LUNG HEMORRHAGE; MALE; PRIORITY JOURNAL;

EID: 66449104159     PISSN: 17550017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmedc.2008.10.016     Document Type: Article

References (9)

1. Hoffmann R.T., Spelsberg F., and Reiser M.F. Lung bleeding caused by tumoral infiltration into the pulmonary artery - minimally invasive repair using microcoils. Cardiovasc Intervent Radiol 30 (2007) 1282-1285
2. Goker H., Haznedaroglu I.C., Ercetin S., Kirazli S., Akman U., Ozturk Y., et al. Haemostatic actions of the folkloric medicinal plant extract Ankaferd blood stopper. J Int Med Res 36 (2008) 163-170
3. ® as a novel experimental treatment modality for upper gastrointestinal bleeding: a case report. Am J Gastroenterol 103 (2008) 2156-2158
4. ® as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy 2008 (in press).
5. ®. J Altern Complement Med 2008 (in press).
6. Kadayifci A., Haznedaroglu I.C., and Savas M.C. Risk of withdrawing chronic anticoagulation without antithrombotic prophylaxis. Am J Gastroenterol 92 (1997) 361-362
7. Im J.H., Fu W., Wang H., Bhatia S.K., Hammer D.A., Kowalska M.A., et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64 (2004) 8613-8619
8. Unsal E., Atalay F., Atikcan S., and Yilmaz A. Prognostic significance of hemostatic parameters in patients with lung cancer. Respir Med 98 (2004) 93-98
9. Mousa S.A., Linhardt R., Francis J.L., and Amirkhosravi A. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Thromb Haemost 96 (2006) 816-821